GEn-1124 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10 (month) in 2mo
ESTIMATED |
READOUT
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
Phase 2 · Respiratory Distress Syndrome, Acute |
GEn1E Lifesciences | GEn-1124 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|